Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
25.78
-0.37 (-1.41%)
Jul 30, 2025, 3:16 PM - Market open
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fresenius Medical Care AG stock has a target of 30, which predicts a 16.37% increase from the current stock price of 25.78.
Price Target: $30 (+16.37%)
Analyst Consensus: Hold
* Price targets were last updated on May 12, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Fresenius Medical Care AG is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $25 → $30 | Hold | Maintains | $25 → $30 | +16.37% | May 12, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $23 → $25 | Hold | Maintains | $23 → $25 | -3.03% | Jan 6, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | -10.78% | Oct 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $24 → $22 | Hold | Maintains | $24 → $22 | -14.66% | Jul 31, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | -6.90% | May 15, 2024 |
Financial Forecast
Revenue This Year
19.87B
from 19.34B
Increased by 2.74%
Revenue Next Year
20.58B
from 19.87B
Increased by 3.60%
EPS This Year
3.71
from 1.83
Increased by 102.49%
EPS Next Year
4.09
from 3.71
Increased by 10.29%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.1B | 22.0B | 22.9B | ||
| Avg | 19.9B | 20.6B | 21.4B | ||
| Low | 18.8B | 19.2B | 19.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.1% | 10.7% | 11.4% | ||
| Avg | 2.7% | 3.6% | 3.8% | ||
| Low | -2.8% | -3.4% | -3.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.45 | 5.33 | 6.38 | ||
| Avg | 3.71 | 4.09 | 4.70 | ||
| Low | 2.13 | 2.30 | 3.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 143.3% | 43.9% | 56.2% | ||
| Avg | 102.5% | 10.3% | 15.0% | ||
| Low | 16.2% | -37.9% | -13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.